Yes, you would certainly put AVX in top handfull of Aussie Pharmas with good drugs in developement. An equity injection to at least fund completion of phase 3 would take the pressure off!!
NVA Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
MND Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
